IE
IE · IE · IE-PA-EU/1/18/1312/003-004
Xerava 100 mg Powder for concentrate for solution for infusion
ATC J01AA13
Last synced from HPRA (Ireland) on
Identification
ManufacturerPaion Pharma GmbH
CountryIE (IE)
ATC codeJ01AA13
Dispensing—
ReimbursedNo
SourceHPRA (Ireland)
Last synced6/8/2026
Packs · 1
- ie_pa_numberEU/1/18/1312/003-004
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Powder for concentrate for solution for infusion",
"routes": [
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"J01AA13"
],
"strength": null,
"pa_number": "EU/1/18/1312/003-004",
"substances": [
"ERAVACYCLINE"
],
"legal_basis": "Known active substance (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "20/09/2018",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}Related drugs
Other records sharing ATC code J01AA13.
Access this data programmatically
Query Xerava 100 mg Powder for concentrate for solution for infusion and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.